Start exploring your own markets for free

🚀 Try for Free

/Remote Monitoring for Biomarkers
Invite

Pending to review

Not sure yet

Interested

Not interested

Showing 29 companies

Download list

Company
Fit assessment
Description
Subspaces
Tags
HQ Location
Founding Date
Employees
Total Funding Raised
Last Funding Event
Received on

Alacrity Care effectively employs remote monitoring technologies and identifies digital biomarkers to enhance patient care and advance clinical trials.

Alacrity Care develops end-to-end solutions that address AE healthcare management needs. They provide integrated data collection and leverage a spectrum of wearables, spot assessment tools, and point-of-care blood analysis. They also provide devices to design a monitoring approach focused on specific AE detection needs. They are specified in digital therapeutics, digital health, and digital care companions.
  • Digital Biomarkers Development
Light Search
Los Angeles (United States)20121 - 10NA
Oct 14, 2024

Evidation develops a health data analytics platform that collects and analyzes everyday behavior data to generate insights about health and diseases. They focus on empowering individuals to participate in health research and improve health outcomes through real-world data.

Evidation measures health in everyday life and enables anyone to participate in groundbreaking research and health programs. Built upon a foundation of user privacy and control over permissioned health data, Evidation's Achievement platform is trusted by millions of individuals—generating data with unprecedented speed, scale, and rigor. We partner with leading healthcare companies to understand health and disease outside the clinic walls. Guided by our mission to enable and empower everyone to participate in better health outcomes, Evidation is working to bring people individualized, proactive, and accessible healthcare—faster. Founded in 2012, Evidation Heath is headquartered in California. We collaborate as a distributed team with additional offices around the globe. To learn more, visit evidation.com, or follow us on Twitter @evidation
  • Digital Biomarkers Development
Light Search
San Mateo (United States)201251 - 200$259.00MSeries E, $153.00M, March 22, 2021
Oct 14, 2024

AliveCor develops mobile ECG devices that allow patients to monitor their heart health using smartphones, providing real-time data and analysis to healthcare professionals for improved cardiac care. Their solutions include AI-driven tools for remote monitoring and management of heart conditions.

Developer of a mobile electrocardiogram device designed to improve stroke prevention through early atrial fibrillation detection. The company's device lets patients monitor their heart health via their smartphones and provides physicians with an additional heart health assessment tool, enabling doctors to instantly analyze and detect atrial fibrillation and normal sinus rhythm in an ECG.
  • Digital Biomarkers Development
Light Search
Mountain View (United States)201051 - 200$154.28MSeries F+, August 16, 2022
Oct 14, 2024

Coviu is a telehealth platform that enhances virtual consultations with AI-backed clinical tools and a variety of integrated applications. It offers features like remote patient monitoring and a marketplace of tools tailored for diverse healthcare specialties.

Coviu is a telehealth startup that helps doctors and health practitioners with AI-backed clinical tools to make the video calling experience with the patient even better than actually seeing the patient in real life. The company offers consultations regarding cardiology, dentistry, dermatology, diabetes, dietetics, endocrinology, Endoscopy. general practice, beauty, naturopathy, nutrition, homeopathy, occupational therapy, child health and pediatrics, orthopedics, psychology, psychotherapy, plastic surgery, speech and language therapy, urology, women’s health, and many more. Its video consultations are enhanced with a range of in-call clinical tools, and its software integrates seamlessly with a range of practice management systems.
  • Patient Engagement and Adherence
Light Search
South Brisbane (Australia)201551 - 200$7.32MSeries A, $6.00M, December 7, 2020
Oct 14, 2024

Koneksa Health excels in remote patient monitoring and digital biomarker development, enhancing clinical trials and disease tracking.

Koneksa Health is a healthcare data analytics company that helps researchers incorporate emerging technologies (bio-sensors, activity trackers, mobile-based questionnaires, etc.) into their clinical studies. Their Koneksa Compare software dashboard enables the collection, visualization, and analysis of these patient-generated data sets. Koneksa currently supports academic and life sciences researchers, expands the universe of data that can be analyzed while also removing subjective characteristics from clinical endpoints. It was founded in 2015 and is based in New York, United States.
  • Digital Biomarkers Development
Light Search
New York (United States)201551 - 200$70.65MGrant, August 8, 2022
Oct 14, 2024

TytoCare is a mobile-health platform that enables self-physical examinations and remote diagnoses through its telehealth products. Their solutions include a modular examination tool and a cloud-based platform for sharing exam data and conducting live video consultations.

TytoCare is a mobile-health platform and device, that allows anyone to perform self-physical examination and remote diagnosis. Tyto Care has three telehealth products: the TytoHome for consumers, TytoPro for professionals, and TytoClinic for remote point-of-care locations. All solutions are designed to replicate a facetious clinician visit and include a modular examination tool for examining the heart, lungs, skin, throat, ears, and body temperature; a complete telehealth platform for sharing exam data, conducting live video exams, and scheduling visits; a cloud-based data repository with analytics; and built-in guidance technology and machine learning algorithms to ensure accuracy and ease of use.
  • Patient Engagement and Adherence
Light Search
New York (United States)201151 - 200$205.70MSeries E, $49.00M, August 3, 2023
Oct 14, 2024

Altoida is pioneering a platform for assessing brain health using augmented reality and machine learning, focusing on early detection of cognitive impairments. Their technology aims to provide objective evaluations of neurological conditions, enhancing clinical trial outcomes and monitoring disease progression.

Altoida is creating a new gold standard in brain health with Precision Neurology. We're radically transforming the method for measuring brain function and diagnosing neurological disease, using just your smartphone or tablet. Our products are backed by more than 20 years of innovative research in digital biomarkers, augmented reality (AR), and artificial intelligence (AI). Altoida received FDA Breakthrough Device Designation in July 2021. Our first device is a Computerized Cognitive Assessment Aid that is classified as Class II, 510(k) exempt.
  • Digital Biomarkers Development
Light Search
Washington (United States)201611 - 50$24.75MSeries A, $14.00M, March 30, 2022
Oct 14, 2024

Verily is a health technology company that focuses on research, care, and health financing, utilizing technology and data science to enhance personalized healthcare. They develop tools and products aimed at improving health outcomes and accelerating evidence generation in the healthcare sector.

Verily is an Alphabet health technology company focused on research, care, and health financing to deliver on the promise of precision health and help people live healthier lives. We are uniquely positioned at the intersection of technology, data science, and healthcare to create tools to accelerate evidence generation, products to enable more personalized care, and approaches to make costs more predictable. For more information about Verily please visit verily.com. The company was founded in 2015 and is based in San Francisco, California, United States.
  • Digital Biomarkers Development
Light Search
South San Francisco (United States)20151001 - 5000$3.50BSecondary Market, September 29, 2022
Oct 14, 2024

VivoSense excels in remote patient monitoring and the development of digital biomarkers, significantly advancing clinical trials and healthcare research.

VivoSense, also known as Vivonoetics are a data analysis and software company specializing in wearable sensor physiological monitoring solutions for research and clinical trials.
  • Digital Biomarkers Development
Light Search
Newport Beach (United States)201011 - 50$27.00MGrant, January 9, 2023
Oct 14, 2024

Orikami excels in remote monitoring technologies, advancing clinical trials, and developing digital biomarkers for personalized healthcare.

Orikami offers 3 service lines that leverage our state-of-the-art data science expertise in health. They work patients included and according to the principles of ISO27001 (data security) and ISO13485 (medical quality management).
  • Digital Biomarkers Development
Light Search
Nijmegen (Netherlands)201111 - 50$659.06KSeed, $659.06K, October 9, 2019
Oct 14, 2024

Use "Get more companies" to continue searching, or run a “Deep Dive” for a comprehensive mapping